Answers are grounded in this paper and cite their sources.
This development demonstrates 100% sensitivity and specificity in detecting respiratory pathogens using a new microfluidic technology.
The development of microfluidic chips for biological and chemical applications is a rapidly evolving field because these devices can perform a complex set of sequential operations on a submillimeter scale. Here, we develop a vacuum-driven microfluidic chip used for multiplexed nucleic acid detection targeting respiratory infectious pathogens, in which we employ conventional side-port puncture needles as valves to connect adjacent functional modules. This design allows a multistep operation from sample introduction to result readout within the vacuum-driven chip. The sensitivity and specificity of detection for clinical respiratory samples in our test both achieved 100% for P. aeruginosa infection. The side-port puncture needle-assisted microfluidic chip represents a promising tool for the rapid and high-throughput molecular analysis in the field of disease diagnosis and environmental monitoring.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: